ROLE OF QUALITY OF LIFE IN HEALTH TECHNOLOGY ASSESSMENT AGENCY FINAL RECOMMENDATIONS: INSIGHTS AND LESSONS FROM REVIEW OF NICE TECHNOLOGY ASSESSMENT REPORTS (2019-2022)

被引：0
|
作者：
Aggarwal, S. [1 ]
Bela, A. [2 ]
Topaloglu, H. [2 ]
Kumar, S. [3 ]
Topaloglu, O. [1 ]
机构：
[1] NOVEL Hlth Strategies, Bethesda, MD USA
[2] NOVEL Hlth Strategies, Chevy Chase, MD USA
[3] NOVEL Hlth Strategies, Columbia, MD USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA83
引用
收藏
页码：S312 / S312
页数：1
相关论文
共 37 条
  • [21] The role of quantitative bias analysis for nonrandomized comparisons in health technology assessment: recommendations from an expert workshop
    Leahy, Thomas P.
    Durand-Zaleski, Isabelle
    Sampietro-Colom, Laura
    Kent, Seamus
    Zoellner, York
    Coyle, Doug
    Casadei, Gianluigi
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2023, 39 (01)
  • [22] How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations
    Marsh, Kevin
    de Bekker-Grob, Esther
    Cook, Nigel
    Collacott, Hannah
    Danyliv, Andriy
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [23] THE ROLE OF ECONOMIC EVALUATION IN THE HEALTH TECHNOLOGY ASSESSMENT (HTA) OF VACCINES-LESSONS LEARNED FROM FINLAND
    Laine, J.
    Soini, E. J.
    Martikainen, J. A.
    VALUE IN HEALTH, 2009, 12 (07) : A432 - A432
  • [24] Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
    Leahy, Joy
    Hickey, Conor
    McConnell, David
    Cassidy, Owen
    Trela-Larsen, Lea
    Barry, Michael
    Tilson, Lesley
    McCullagh, Laura
    VALUE IN HEALTH, 2020, 23 (11) : 1423 - 1426
  • [25] An Innovative Approach to Benefit-Risk Assessment Addressing Quality and Efficiency with Transformative Technology: Insights and Lessons from a Pilot Initiative
    Bhattacharya, Mondira
    Sayre, Tobias
    Frimpter, Jeff
    Snyder, Scott
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 493 - 493
  • [26] Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018-2022: A comparison Between Manufacturer and Common Drug Review analyses
    Levine, Mitchell A. H.
    Fashami, Fatehmeh Mirzayeh
    Tarride, Jean Eric
    Sadeghirad, Behnam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 546 - 547
  • [27] Feasibility of self-reported health related quality of life assessment with older people in residential care: insights from the application of eye tracking technology
    Milte, Rachel
    Crocker, Matthew
    Lay, Kiri
    Ratcliffe, Julie
    Mulhern, Brendan
    Norman, Richard
    Viney, Rosalie
    Khadka, Jyoti
    QUALITY OF LIFE RESEARCH, 2023, 32 (12) : 3557 - 3569
  • [28] Feasibility of self-reported health related quality of life assessment with older people in residential care: insights from the application of eye tracking technology
    Rachel Milte
    Matthew Crocker
    Kiri Lay
    Julie Ratcliffe
    Brendan Mulhern
    Richard Norman
    Rosalie Viney
    Jyoti Khadka
    Quality of Life Research, 2023, 32 : 3557 - 3569
  • [29] Oncology drugs and added benefit: insights from 3 European health technology assessment agencies on the role of efficacy endpoints
    Smith, Nathaniel
    Fu, An-Chen
    Fisher, Tim
    Meletiche, Dennis
    Pawar, Vivek
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 1 - 6
  • [30] Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses
    Mirzayeh Fashami, Fatemeh
    Tarride, Jean-Eric
    Sadeghirad, Behnam
    Hariri, Kimia
    Peyrovinasab, Amirreza
    Levine, Mitchell
    PHARMACOECONOMICS-OPEN, 2024, 8 (06) : 823 - 836
1234